Table 3.
Clinical characteristics of patients with cryoglobulins.
| Patient | Sex | Age | Acute/Chronic | Type of Tx | Immuno-Suppression | PLT (109/L) |
WBC (109/L) |
Lymph. (109/L) |
|---|---|---|---|---|---|---|---|---|
| #1 | M | 55 | Acute | - | - | 155 | 4.3 | 1.36 |
| #2 | M | 45 | Chronic | Kidney | Tac/MMF/S | 227 | 3.8 | 1.55 |
| #3 | M | 56 | Chronic | Heart | Eve/MMF | 230 | 5.8 | 1.21 |
| #4 | M | 58 | Chronic | Kidney | S * | 153 | 4.7 | 1.05 |
| #5 | M | 46 | Chronic | Heart | Eve/MMF/S | 348 | 6.4 | NA |
Tx, transplantation; Tac, tacrolimus; Eve, everolimus; MMF, mycophenolate mofetil; S., steroid; PLT, platelet count; WBC, white blood cells; Lymph., lymphocyte count; NA, not available. * Patient #4 (2× kidney Tx, state after rituximab therapy due to repeated rejection) had weak immunosuppression with steroids monotherapy, due to chronic transplant nephropathy.